BF.B
48
-5
ABT
63
-2
VNO
57
3
VIX
54
-9
VRSN
58
8
AA
34
-3
BBY
48
3
FAST
59
-4
KMI
57
2
NWSA
78
3
CMCSA
52
4
FSLR
47
3
PLD
35
-2
TRIP
47
3
WU
30
2
KO
55
-12
PNR
71
2
KMB
39
11
CAH
61
3
AMAT
52
2
BF.B
48
-5
ABT
63
-2
VNO
57
3
VIX
54
-9
VRSN
58
8
AA
34
-3
BBY
48
3
FAST
59
-4
KMI
57
2
NWSA
78
3
CMCSA
52
4
FSLR
47
3
PLD
35
-2
TRIP
47
3
WU
30
2
KO
55
-12
PNR
71
2
KMB
39
11
CAH
61
3
AMAT
52
2
Financhill
Back

Verisk Analytics Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Buy
63

VRSK
Verisk Analytics

Last Price:
$285.95
Seasonality Move:
6.81%
Buy
63

RYTM
Rhythm Pharmaceuticals

Last Price:
$63.69
Seasonality Move:
15.42%
Buy
63
Verisk Analytics (VRSK) is a Buy

Is Verisk Analytics a Buy, Sell or Hold?

  • The current Verisk Analytics [VRSK] share price is $286.05. The Score for VRSK is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • VRSK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $63.76. The Score for RYTM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VRSK Stock Price Chart

What is Verisk Analytics's stock price today?

  • The Verisk Analytics share price today is $286.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing slight buying pressure.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $63.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRSK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 45.86 Sell
Chaikin Money Flow: 234468 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (284.2 - 297.14) Sell
Bollinger Bands (100): (279.39 - 295.29) Sell

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.28 Buy
Relative Strength Index (14 RSI): 63.66 Buy
Chaikin Money Flow: 369446 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.02 - 61.16) Buy
Bollinger Bands (100): (53.03 - 59.91) Buy

VRSK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 290.21 Sell
20-day SMA: 290.98 Sell
50-day SMA: 292.05 Sell
200-day SMA: 279.89 Buy
8-day EMA: 289.15 Sell
20-day EMA: 290.13 Sell
50-day EMA: 289.9 Sell
200-day EMA: 278.29 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.43 Buy
20-day SMA: 57.42 Buy
50-day SMA: 55.27 Buy
200-day SMA: 53.46 Buy
8-day EMA: 61.16 Buy
20-day EMA: 58.64 Buy
50-day EMA: 56.64 Buy
200-day EMA: 52.62 Buy

Verisk Analytics Earnings Growth & VRSK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.86 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.

Verisk Analytics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):